Himachal assembly winter session from Dec 16 Shimla's IIAS to remain closed every Monday HPCA to dedicate museum to Tendulkar Himachal Pradesh to set up controlled atmosphere stores Shimla, Nov 27 (IANS) A British-era building decaying from ... Taaza.com, 1 week ago
Shimla's IIAS to remain closed every Monday - Prokerala, 2 weeks ago
Word on the street is that FIIs voted in favour of the deal heeding the advice of foreign proxy firms ISS and Glass Lewis.Money Control, 1 week ago
In an interview with ET Now, Amit Tandon, MD, IIAS, shares his views on the ACC-Ambuja deal. In an interview with ET Now, Amit Tandon, MD, IIAS, shares his views on the ACC-Ambuja deal. Excerpts: ET Now: If indeed more than 50% of the people vote against the ...Economic Times, 2 weeks ago Ambuja-Holcim deal pass test, get minority shareholder nod Moneycontrol.com, 1 week ago
Last financial year, the rise in royalties paid by the Indian subsidiaries of foreign companies was much more than the rise in their revenues or profits. In its latest report, proxy advisory and corporate governance firm Institutional Investor Advisory ...Business Standard, 2 months ago High royalty payment remains a concern for investors: IiAS Business Standard, 2 months ago
Investor sentiment, by many metrics, has become excessively bullish again. Investors Intelligence Advisors Sentiment (IIAS) [http://www.investorsintelligence.com/x/default.html] is one of our favorites which as of their last survey reported 52.6% ...Mr Top Step, 2 weeks ago
MELBOURNE, Australia--(BUSINESS WIRE)--Patrys Limited (ASX:PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma (MM) will be presented at the 55th American ...BioSpace, 1 day ago Patrys Posts Data from Final Cohort of Patients in Multiple Myeloma Clinical Trial [Professional Services Close - Up] Pharmacy Choice, 4 hours ago Patrys to present final results of PAT-SM6 clMultiple Myeloma Clinical Trial at American Society of Haematology conference Individual.com, 5 days ago Data from Patrys' PAT-SM6 Phase I/IIa trial in multiple myeloma to be presented at ASH Annual Meeting News-Medical.Net, 5 days ago
More from: OSIX News, CNBC...and 11 other sources
WASHINGTON , Dec. 4 -- The U.S. Department of Commerce published the following notice in the Federal Register : Drawn Stainless Steel Sinks From the People's Republic of China: Initiation of New Shipper Review A Notice by the International Trade ...Kitco, 7 hours ago
Fujifilm joins forces with a largest U.S. Alzheimer's Disease therapeutic research consortium to conduct clinical trial of the Alzheimer's Disease drug "T-817MA".
FUJIFILM Corporation (President: Shigehiro Nakajima) has decided to partner with the Alzheimer's Disease Cooperative Study (hereinafter "ADCS"),* the largest Alzheimer's Disease therapeutic research consortium in the United States, to carry out a ...Noodls, 10 hours ago
Medgenics ' ( LON:MEDG ) chairman has bought his second sizeable chunk of shares in the drug delivery innovator in little over two weeks. Dr Sol Barer bought 20,000 shares at US$6.589 at a total cost of aroud US$132,000. In November, Barer bought ...Proactive Investors.co.uk, 1 day ago
Cytokinetics Announces Closing of Enrollment Into BENEFIT-ALS, A Phase IIb Clinical Trial of Tirasemtiv in Patients with Amyotrophic Lateral Sclerosis
Results Are Expected in First Half of 2014 South San Francisco, CA, December 3, 2013 - Cytokinetics, Incorporated (Nasdaq: CYTK) announced that the company has closed recruitment and enrollment of patients into BENEFIT-ALS (Blinded Evaluation of ...Benzinga.com, 1 day ago
on your WebpageAdd Widget >Get your members hooked!